Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106957878B reveals a novel enzymatic route for 2-phenethyl alcohol using L-phenylalanine. Achieves high conversion without toxic byproducts, offering a reliable supply chain solution.
Patent CN113735752A reveals a novel metal-free route for S-aryl isothiourea synthesis, offering significant cost reduction and simplified supply chains for API manufacturing.
Patent CN111072555A details a green HEH-catalyzed method for heterocyclic sulfones, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN116730905B reveals Pd-catalyzed carbonylation for spiroindoline. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediate manufacturing.
Novel copper-catalyzed method for 3,5-dichloroaniline. Reduces cost and environmental impact. Reliable supply for agrochemical intermediates.
Patent CN105085275A introduces a green ortho-nitration method. Enhance supply chain reliability and reduce purification costs with high-selectivity pharma intermediates.
Patent CN104910079B reveals efficient one-pot oxidation for 4(3H)-quinazolinone derivatives. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel copper-catalyzed synthesis of 3 5-dichloroaniline offers cost reduction and supply chain reliability for agrochemical intermediate manufacturing globally.
Advanced melt crystallization patent CN107266294A ensures 99.5% purity. Reduces energy consumption and improves supply chain reliability for global buyers.
Patent CN110386885A enables metal-free visible light synthesis of β-carbonyl sulfones. Achieve cost reduction in fine chemical manufacturing with scalable, green protocols.
Novel Mn-catalyzed method offers high selectivity and mild conditions for alkynyl silane manufacturing, ensuring supply chain reliability and cost efficiency.
Patent CN118085036B enables aqueous cyclization reducing solvent waste. Offers supply chain reliability and cost reduction in peptide manufacturing for global partners.
Patent CN107513048A details a high-yield synthetic route for deuterated Vortioxetine hydrobromate offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107674072B reveals a scalable resolution method for dihydropyrimidine intermediates using L-tartaric acid, offering superior optical purity and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN112661802B reveals a scalable, non-toxic route for 3'-methoxyguanosine, offering significant cost reduction and supply chain reliability for mRNA cap analog manufacturing.
Patent CN112661802B reveals a scalable synthesis of 3'-methoxyguanosine, offering cost reduction in mRNA cap analog manufacturing and reliable supply chain solutions.
Patent CN102516351A details novel ursolic acid derivatives with enhanced anti-cancer activity and reduced toxicity, offering cost reduction in API manufacturing.
Patent CN111170958A details a green solid-acid catalyzed route for hydroxybenzomorph, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108047179A details a one-step catalytic method for fullerene dihydrofuran compounds, offering simplified manufacturing and enhanced supply chain reliability for advanced material intermediates.
Patent CN102936214B details a green synthesis of H acid using mother liquor recycling and hydrogenation, reducing waste by over 80% for reliable dye intermediate supply.